Cytotherapy and Longevity (CL), upholding the core mission of "Cell Therapy Promoting Skeletal Health and Functional Longevity," advances collaborative innovation in cell therapy, mechanobiology, and the prevention and treatment of degenerative skeletal diseases. It focuses on multidisciplinary intersections related to cell therapy and skeletal aging, covering the full-chain research spectrum including stem cell resources and mechanobiological regulation, development and clinical translation of targeted cell-based therapeutics for osteoarticular disorders, cell culture and process optimization under mechanical microenvironments, cellular functional assays and clinical efficacy data application, intelligent mechano-intervention technologies and equipment development, and therapeutic efficacy studies of cell therapy in degenerative diseases. The journal features dedicated columns such as "Reviews and Prospects" and "Technical Exchanges and Case Studies," systematically presenting the latest advances in cell technology for delaying musculoskeletal aging and enhancing motor function and quality of life, while providing technical support for related clinical practice and industrial development.